Medicinal Products Transparency Disclosure: Healthcare Professionals and Organisations
Medical Devices Transparency Disclosure: Healthcare Organisations
Interactions with Members of the Public, Patients and Journalists
Collaborative Working with Organisations
Please see below the patient organisations Norgine provided financial and/or non-financial support or engaged with through contracted services over the last 3 years, as well as the method to better understand the data provided including the significance of the support and the monetary value of such support.
UK-COR-NP-2500002
In line with the EFPIA Code of Practice and various country Disclosure Codes and legal requirements for transparency, Norgine is disclosing its interactions and relevant transfers of value with healthcare professionals and healthcare organisations. This information includes the support to healthcare organisations in the form of donations and grants, as well as benefits in kind and sponsorship agreements to manage an event. It also covers the support to healthcare professionals with contributions to cost of events, including registration fees, travel and accommodation, as well as service and consultancy fees and related expenses that may arise. Transfers of value associated with Research and Development are also provided.
Norgine also publishes information from Australia and New Zealand.
Please click on the relevant country icon to view the information related to medicinal products:
If a flag for a particular European country is not displayed below, Norgine has not had interactions or transfers of value data to report for that country over the last 3 years. Please also note that Norgine works with third parties in some countries and it is the responsibility of the third party to report any qualifying interactions publicly.
In line with the MedTech Code of Practice, Norgine is publishing its interactions and relevant transfers of value with European healthcare organisations, in terms of educational grants. This information typically includes educational grants to healthcare organisations in the form of support to third party organised events, healthcare professionals participation at third party organised educational events, scholarship, fellowship and grants for public awareness campaigns. Please note that direct sponsorship to healthcare professionals is not allowed.
Click below to view the information related to Medical Devices:
Please find French Medical Device disclosure under: https://www.transparence.sante.gouv.fr
2024: No Medical Device data to disclose (2023 data)
2023 Medical Device Transparency Declaration (2022 data)
2022 Medical Device Transparency Declaration (2021 data)
Where the requirement to disclose transfers of value to Members of the Public, Patients and Journalists exist, the information is presented below. If information is not visible for a country, Norgine is not required to disclose such transfers of value as per local Codes of Practice. The information provided will typically include the fees paid and any associated expenses, as well as the type of service that was provided, e.g. speaking at meetings, providing assistance with training, advising on the design of clinical trials, participating in market research with remuneration and/or travel, participating in advisory boards, writing articles or publications.
United Kingdom
2023 Annual Disclosure for Members of the Public and Patients
2022 Annual Disclosure for Members of the Public and Patients
2021 Annual Disclosure for Members of the Public and Patients
Norgine is involved in collaborative working projects which either enhances patient care or are for the benefit of patients, or alternatively benefits the Health Services (e.g. NHS in UK) and, as a minimum, maintains patient care. Find out more about these projects by reading the executive summaries below.
United Kingdom
Patient Information Forum – Being Induced Survey – Executive Summary
Norgine websites
Contact us